Logo image of IVDA

IVEDA SOLUTIONS INC (IVDA) Stock Fundamental Analysis

NASDAQ:IVDA - Nasdaq - US46583A3032 - Common Stock - Currency: USD

1.92  -0.03 (-1.54%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IVDA. IVDA was compared to 284 industry peers in the Software industry. While IVDA seems to be doing ok healthwise, there are quite some concerns on its profitability. IVDA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IVDA had negative earnings in the past year.
In the past year IVDA has reported a negative cash flow from operations.
IVDA had negative earnings in each of the past 5 years.
In the past 5 years IVDA reported 4 times negative operating cash flow.
IVDA Yearly Net Income VS EBIT VS OCF VS FCFIVDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2019 2020 2021 2022 2023 0 -1M -2M -3M -4M -5M

1.2 Ratios

IVDA has a Return On Assets of -35.93%. This is in the lower half of the industry: IVDA underperforms 77.82% of its industry peers.
IVDA's Return On Equity of -57.49% is on the low side compared to the rest of the industry. IVDA is outperformed by 69.01% of its industry peers.
Industry RankSector Rank
ROA -35.93%
ROE -57.49%
ROIC N/A
ROA(3y)-59.62%
ROA(5y)-73.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVDA Yearly ROA, ROE, ROICIVDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2019 2020 2021 2022 2023 0 200 400

1.3 Margins

The Gross Margin of IVDA (23.59%) is worse than 79.58% of its industry peers.
IVDA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IVDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.82%
GM growth 5YN/A
IVDA Yearly Profit, Operating, Gross MarginsIVDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

IVDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IVDA has less shares outstanding
The debt/assets ratio for IVDA has been reduced compared to a year ago.
IVDA Yearly Shares OutstandingIVDA Yearly Shares OutstandingYearly Shares Outstanding 2015 2019 2020 2021 2022 2023 5M 10M 15M
IVDA Yearly Total Debt VS Total AssetsIVDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2019 2020 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

IVDA has an Altman-Z score of -6.83. This is a bad value and indicates that IVDA is not financially healthy and even has some risk of bankruptcy.
IVDA has a worse Altman-Z score (-6.83) than 85.92% of its industry peers.
IVDA has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.12, IVDA is in line with its industry, outperforming 51.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -6.83
ROIC/WACCN/A
WACC10.54%
IVDA Yearly LT Debt VS Equity VS FCFIVDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

IVDA has a Current Ratio of 2.45. This indicates that IVDA is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.45, IVDA is doing good in the industry, outperforming 67.96% of the companies in the same industry.
IVDA has a Quick Ratio of 2.04. This indicates that IVDA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of IVDA (2.04) is better than 61.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.04
IVDA Yearly Current Assets VS Current LiabilitesIVDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

6

3. Growth

3.1 Past

IVDA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -700.55%.
Looking at the last year, IVDA shows a very negative growth in Revenue. The Revenue has decreased by -30.10% in the last year.
Measured over the past years, IVDA shows a very strong growth in Revenue. The Revenue has been growing by 63.73% on average per year.
EPS 1Y (TTM)-700.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-424.8%
Revenue 1Y (TTM)-30.1%
Revenue growth 3Y63.73%
Revenue growth 5YN/A
Sales Q2Q%175.66%

3.2 Future

IVDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.53% yearly.
IVDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 80.75% yearly.
EPS Next Y89.26%
EPS Next 2Y47.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.96%
Revenue Next 2Y80.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IVDA Yearly Revenue VS EstimatesIVDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
IVDA Yearly EPS VS EstimatesIVDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.5 -1 -1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

IVDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 8.18 indicates a reasonable valuation of IVDA.
Based on the Price/Forward Earnings ratio, IVDA is valued cheaper than 93.31% of the companies in the same industry.
IVDA is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 8.18
IVDA Price Earnings VS Forward Price EarningsIVDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVDA Per share dataIVDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IVDA's earnings are expected to grow with 47.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.53%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IVEDA SOLUTIONS INC

NASDAQ:IVDA (5/16/2025, 5:20:01 PM)

1.92

-0.03 (-1.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-15 2025-04-15/amc
Earnings (Next)05-19 2025-05-19/bmo
Inst Owners5%
Inst Owner Change-0.26%
Ins Owners5%
Ins Owner Change0%
Market Cap5.40M
Analysts82.86
Price Target8.16 (325%)
Short Float %0.84%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-22.9%
Min Revenue beat(2)-39.84%
Max Revenue beat(2)-5.95%
Revenue beat(4)0
Avg Revenue beat(4)-47.95%
Min Revenue beat(4)-86.43%
Max Revenue beat(4)-5.95%
Revenue beat(8)1
Avg Revenue beat(8)-35.95%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.18
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 1.19
EV/EBITDA N/A
EPS(TTM)-1.33
EYN/A
EPS(NY)0.23
Fwd EY12.22%
FCF(TTM)-1.61
FCFYN/A
OCF(TTM)-1.4
OCFYN/A
SpS1.89
BVpS2.02
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.93%
ROE -57.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.59%
FCFM N/A
ROA(3y)-59.62%
ROA(5y)-73.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.82%
GM growth 5YN/A
F-Score2
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2458.47%
Cap/Sales 10.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 2.04
Altman-Z -6.83
F-Score2
WACC10.54%
ROIC/WACCN/A
Cap/Depr(3y)1528.45%
Cap/Depr(5y)930.4%
Cap/Sales(3y)4.93%
Cap/Sales(5y)3.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-700.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-424.8%
EPS Next Y89.26%
EPS Next 2Y47.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.1%
Revenue growth 3Y63.73%
Revenue growth 5YN/A
Sales Q2Q%175.66%
Revenue Next Year-0.96%
Revenue Next 2Y80.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.7%
OCF growth 3YN/A
OCF growth 5YN/A